Schedule 13G ownership disclosure

Fixed Income Clearing Corp.

Security class unavailable · CUSIP: 000000000

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,524,887
Percent of class
9.8400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-24-005666
Form type
SC 13G/A
Filer
Eton Pharmaceuticals, Inc.
CIK
CIK 1710340
Filed
Feb 09, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub